TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 68 filers reported holding TELA BIO INC in Q2 2024. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,246,464 | -25.6% | 903,503 | -10.2% | 0.00% | – |
| Q1 2024 | $5,704,315 | -13.7% | 1,006,052 | +0.7% | 0.00% | – |
| Q4 2023 | $6,612,407 | -15.3% | 998,853 | +2.3% | 0.00% | – |
| Q3 2023 | $7,808,024 | -11.3% | 976,003 | +12.4% | 0.00% | – |
| Q2 2023 | $8,798,098 | +16.4% | 868,519 | +22.3% | 0.00% | – |
| Q1 2023 | $7,558,305 | -2.7% | 710,367 | +5.2% | 0.00% | – |
| Q4 2022 | $7,765,203 | +132.8% | 675,235 | +72.4% | 0.00% | – |
| Q3 2022 | $3,336,000 | +21.5% | 391,568 | 0.0% | 0.00% | – |
| Q2 2022 | $2,745,000 | -39.7% | 391,568 | 0.0% | 0.00% | – |
| Q1 2022 | $4,554,000 | +2.3% | 391,568 | +12.5% | 0.00% | – |
| Q4 2021 | $4,453,000 | -7.9% | 347,935 | -1.7% | 0.00% | – |
| Q3 2021 | $4,836,000 | -12.3% | 353,969 | +3.4% | 0.00% | – |
| Q2 2021 | $5,514,000 | -11.8% | 342,280 | -18.4% | 0.00% | – |
| Q1 2021 | $6,251,000 | +4.2% | 419,520 | +5.2% | 0.00% | – |
| Q4 2020 | $5,998,000 | -11.4% | 398,799 | -2.5% | 0.00% | – |
| Q3 2020 | $6,766,000 | +115.1% | 409,048 | +68.5% | 0.00% | – |
| Q2 2020 | $3,145,000 | +704.3% | 242,692 | +385.4% | 0.00% | – |
| Q1 2020 | $391,000 | -39.6% | 50,000 | 0.0% | 0.00% | – |
| Q4 2019 | $647,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,110,709 | $19,320,332 | 6.30% |
| Stonepine Capital Management, LLC | 625,645 | $2,940,532 | 2.70% |
| AIGH Capital Management LLC | 1,656,655 | $7,786,278 | 2.42% |
| Velan Capital Investment Management LP | 746,087 | $3,506,609 | 2.01% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $4,700,000 | 1.11% |
| PERKINS CAPITAL MANAGEMENT INC | 204,350 | $960 | 0.90% |
| Nantahala Capital Management | 2,445,667 | $11,494,635 | 0.68% |
| Meros Investment Management, LP | 152,718 | $717,775 | 0.34% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,256,200 | $5,904,140 | 0.27% |
| Orbimed Advisors | 2,457,542 | $11,550,447 | 0.23% |